Lect. TUĞRUL ELVERDİ

Publication Network

Articles 28

1. Salvage radiotherapy in refractory adult Hodgkin and non-Hodgkin lymphoma

Hekim M. V., ERGEN Ş. A., ELVERDİ T., Özmen İbiş D., Çolpan Öksüz D.

International Journal of Hematology , vol.123, no.6, pp.876-884, 2026 (SCI-Expanded, Scopus)

2. Acquired angioedema due to C1 inhibitor deficiency: real-world clinical characteristics and treatment outcomes

Toprak I. D., ERDEM S., Korkmaz P., Unal D., YEĞİT O. O., Hormet Igde M., et al.

FRONTIERS IN IMMUNOLOGY , vol.17, 2026 (SCI-Expanded, Scopus)

3. Plasma Cell Contamination in Autografts Determined by Dual Quantification Before Cryopreservation and After Thawing Predicts Transplant Outcomes in Multiple Myeloma: A Prospective, Proof-of-Concept Study

Yilmaz U., ELVERDİ T., BAYAR M., ZULFALIYEVA G., Çavuşoğlu M., Ozmen D., et al.

Cerrahpaşa Medical Journal , no.1, pp.1-8, 2026 (TRDizin)

4. Navigating biosimilar transitions in IV rituximab therapy: Efficacy and safety insights from a real-world switching study.

Erçalışkan A., Seyhan Erdoğan D., Bahar F., Belli Ç., Ortaboz D., Elverdi T., et al.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners , 2026 (SCI-Expanded, Scopus)

5. Thrombolytic potential of the “hydrodynamic cavitation on a chip” concept: insights into clot degradation

Yetisgin A. A., Ozogul B., Akar U., Mercimek R., Sarraf S. S., ELVERDİ T., et al.

Lab on a Chip , vol.26, no.1, pp.24-39, 2026 (SCI-Expanded, Scopus)

6. Simplified Molecular International Prognostic Index as an eligibility criterion for clinical trials: Analysis of the Turkish Lymphoma Study Group's large B-cell lymphoma cohort

YILMAZ U., TERZİ DEMİRSOY E., KEKLİK KARADAĞ F., Hatipoglu U., Ulukoylu Menguc M., Pekguc E., et al.

BRITISH JOURNAL OF HAEMATOLOGY , vol.208, no.1, pp.139-148, 2026 (SCI-Expanded, Scopus) Sustainable Development

7. National Perspectives on Academic CAR-T Cell Therapy in Türkiye: A Report from the Turkish Society of Hematology's Scientific Subcommittee on Cell and Gene Therapies (TSH-CGT SSC)

YÜKSEL M., Yalcin K., ELVERDİ T., Yeral M., SOYER N., Aki S. Z., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.43, no.3, pp.274-279, 2026 (SCI-Expanded, Scopus, TRDizin)

8. Exploring an independent association between rituximab-cyclophosphamide-doxorubicin-vincristine-prednisolone dose intensity and clinical outcomes in large B-cell lymphoma: Analyses of subsequent endpoints following a complete response in a real-world cohort of 1369 patients

YILMAZ U., Dal M. S., Ulaş T., Ateşoğlu E. B., Keklik Karadağ F., Mengüç M. U., et al.

Cancer , vol.132, no.1, 2026 (SCI-Expanded, Scopus)

9. Determinants of Survival in Mantle Cell Lymphoma: A 20-Year Single-Center Retrospective Analysis

Muradov I., Polat A. O., ELVERDİ T., SALİHOĞLU A., AR M. C., Öngören Ş., et al.

Indian Journal of Hematology and Blood Transfusion , 2026 (SCI-Expanded, Scopus)

10. Is splenectomy one of the contributory factors to pulmonary hypertension? An analysis of splenectomized hemolytic anemia and immune thrombocytopenia patients.

Birsin Z., Salihoğlu A., Tokdil K. O., Pirdal B. Z., Bilgiç S., Avcı B. K., et al.

Annals of hematology , vol.104, pp.4447-4456, 2025 (SCI-Expanded, Scopus)

11. Upregulation of SPINK2 in acute myeloid leukemia

Gezer S., Emrence Z., Elverdi T., Ar M. C., Yaylaz B. S., Pacal F., et al.

ADVANCES IN LABORATORY MEDICINE-AVANCES EN MEDICINA DE LABORATORIO , vol.4, no.1, pp.92-97, 2023 (ESCI, Scopus)

12. SPINK2 elevation in acute myeloid leukemia Elevación de SPINK2 en leucemia mieloide aguda

Gezer S., EMRENCE Z., ELVERDİ T., AR M. C., Salman Yaylaz B., PAÇAL F., et al.

Advances in Laboratory Medicine , vol.4, no.1, pp.98-104, 2023 (ESCI, Scopus)

13. The Effect of Smoking on Inactivated and mRNA Vaccine Responses Applied to Prevent COVİD-19 in Multiple Sclerosis

Şen S., Arslan G., Tütüncü M., Demir S., Dinç Ö., GÜNDÜZ T., et al.

Noropsikiyatri Arsivi , vol.60, no.3, pp.252-256, 2023 (SCI-Expanded, Scopus, TRDizin)

14. A Potential Target for Treating Acute Myeloid Leukemia: XBP1 involved in Endoplasmic Reticulum Stress

Biberoglu N. E., Punar S., Ekmekci S. S., AR M. C., Unuvar A., EMRENCE Z., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.38, pp.488-495, 2023 (ESCI, Scopus, TRDizin)

15. A cross-sectional study on restless legs syndrome (RLS) in polycythemia vera (PV): is iron deficiency the only culprit?

Seyhan Erdoğan D., Benbir Şenel G., Gündüz A., Uçar B. P., Elverdi T., Salihoğlu A., et al.

Neurological Research , vol.45, no.12, pp.1144-1151, 2023 (SCI-Expanded, Scopus)

16. Clinical Outcomes of CNS Lymphoma Treated with Ibrutinib-Based Therapy: A Real-Life Multicenter Experience on Off-Label Use of Ibrutinib

ILTAR U., SALİM O., Atas U., Vural E., Alhan F. N., YÜCEL O. K., et al.

UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , no.4, pp.191-197, 2023 (SCI-Expanded, Scopus) Sustainable Development

17. Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic ⁎

Küçükyurt S., Şahin K., Yılmaz U., Erçalışkan A., Özkan Tekin T., Ortaboz D., et al.

Current Problems in Cancer , vol.46, no.6, 2022 (SCI-Expanded, Scopus) Sustainable Development

18. A new dawn for upfront autologous SCT in NK/T-cell lymphomas: One more step forward in reasoning

Elverdi T., Hıyamlı M. F., Şahin B., Eşkazan A. E.

INTERNATIONAL JOURNAL OF CANCER , vol.151, no.5, pp.661-664, 2022 (SCI-Expanded, Scopus)

19. The outcome of patients with Hodgkin lymphoma and early relapse after autologous stem cell transplant has improved in recent years

Bazarbachi A., Boumendil A., Finel H., Khvedelidze I., Romejko-Jarosinska J., Tanase A., et al.

LEUKEMIA , vol.36, no.6, pp.1646-1653, 2022 (SCI-Expanded, Scopus)

20. Eltrombopag in the Treatment of Immune Thrombocytopenia: Two-Center Experience from Istanbul

Dogan E. E., Erkek E. T., Elverdi T., Kamaci S. C., Ciftci U., Demirel N., et al.

INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION , vol.38, no.2, pp.327-332, 2022 (SCI-Expanded, Scopus) Sustainable Development

21. Treatment Responses, Toxicity, and Survival in Patients with Classical Hodgkin Lymphoma Aged >= 50 Years: A Single-Center Experience Over Two Decades

Çokgezer S., Elverdi T., Salihoğlu A., Ar M. C., Öngören Ş., Başlar Z., et al.

CANCER MANAGEMENT AND RESEARCH , vol.14, pp.1911-1921, 2022 (SCI-Expanded, Scopus)

22. Successful Treatment Of Bulky Abdominal Plasmacytomas With Radiotherapy and Pomalidomide

Barlas C., Dağdelen M., Elverdi T., Salihoğlu A., Öner Dinçbaş F.

EASTERN JOURNAL OF MEDICINE , vol.27, no.2, pp.330-332, 2022 (Scopus, TRDizin)

23. Biosimilar Rituximab (Redditux) Added to CHOP Chemotherapy for De Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single-Center Experience Biyobenzer Rituksimab (Redditux) ile CHOP Kemoterapisinin Yeni Tanı Diffüz Büyük B-Hücreli Lenfoma Hastalarında Kullanımı: Gerçek Yaşam Tek Merkez Deneyimi

Özbalak M., Güzel Mastanzade M., Özlük Ö., Tiryaki T. O., Erdem S., Özbalak E. P., et al.

Turkish Journal of Hematology , vol.39, no.4, pp.254-261, 2022 (SCI-Expanded, Scopus, TRDizin)

24. Castleman Disease: A Multicenter Case Series from Turkey

GÜNDÜZ E., KIRKIZLAR H. O., Umit E. G., KARAMAN GÜLSARAN S., ÖZKOCAMAN V., ÖZKALEMKAŞ F., et al.

TURKISH JOURNAL OF HEMATOLOGY , vol.39, no.2, pp.130-135, 2022 (SCI-Expanded, Scopus, TRDizin)

25. Genetic Features and TP53 Mutations in Chronic Lymphocytic Leukemia

Özünal I. E., , Elverdi T., Salihoğlu A., Eşkazan A. E., Ar M. C., et al.

Cerrahpasa Medical Journal , vol.45, no.3, 2021 (TRDizin)

26. The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience

Kucukyurt S., Şahin K., Yılmaz U., Erçalışkan A., Özkan Tekin T., Ortaboz D., et al.

Blood , vol.138, no.Supplement 1, 2021 (SCI-Expanded, Scopus)

27. R-CHOP Chemotherapy Including Biosimilar Rituximab (Redditux ®) for De-Novo Diffuse Large B-Cell Lymphoma Patients: Real-Life Single Center Experience

Ozbalak M., Mastanzade M., Ozluk O., Tiryaki T. O., Erdem S., Pınar Özbalak E., et al.

Blood , vol.138, no.Supplement 1, 2021 (SCI-Expanded, Scopus)

28. Treatment Responses, Toxicity and Survival in Patients with Classical Hodgkin Lymphoma Aged 50 Years and Older: A Single-Center Experience over 2 Decades

Çokgezer S., Elverdi T., Salihoğlu A., Ar M. C., Öngören Ş., Başlar Z., et al.

Blood , vol.138, no.Supplement 1, 2021 (SCI-Expanded, Scopus)

Papers Presented at Peer-Reviewed Scientific Conferences 4

1. Retrospective Analysis of Prognostic Factors and Survival in Multiple Myeloma Patients Aged 65 Years or Older at Diagnosis in a Real-Life Setting and a Proposed New Staging System

TUNÇ A., GULIYEV M., Tekin T. O., Kucukyurt S., YILMAZ U., NUHOĞLU KANTARCI F. E., et al.

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, pp.12518-12519, (Summary Text)

2. Restless Legs Syndrome (RLS) in Patients (pts) with Polycythemia Vera (PV): Is Iron Deficiency (ID) the Only Culprit?

Erdogan D. S., BENBİR ŞENEL G., GÜNDÜZ A., Ucar B. P., ELVERDİ T., SALİHOĞLU A., et al.

64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 10 - 13 December 2022, pp.12278-12279, (Summary Text)